GBS Screening and Treatment

January 12, 2017

This webinar qualifies for the NARM Category 3 Bridge Certificate

View Recording

 This webinar covered the etiology of Group Beta Strep, as well as historical and current best screening practices. In addition, the pharmacology of treatment was discussed.

Dr. Tolulope Adebanjo, Epidemic Intelligence Service Officer in the Respiratory Diseases Branch at the Centers for Disease Control and Prevention, offered an overview of GBS, the history of GBS screening, and current guidelines for prevention of GBS disease in newborns.
PDF of Tolu Adebanjo’s Presentation slides here

Vicki Penwell, CPM, explained the pharmacology of IV antibiotic treatment for Group Beta Strep in community settings. Vicki is cofounder of Mercy in Action, a nonprofit organization establishing birth centers for poor families in the Philippines since 1992 and now the Mercy in Action College of Midwifery located in Boise, Idaho. She regularly offers seminars and other continuing education courses, including “Expect the Unexpected: Midwives Handling Complications in Out-of-Hospital Settings” a four day intensive that is part of a series that meets the NARM Bridge Certificate requirements.
PDF of Vicki Penwell’s Presentation slides here